Burlington, MA, United States of America

Andrew Pow

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft, Compugen Ltd. Corporation. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Pow. Retrieved from https://idiyas.com/inventor/andrew-pow-3g817fkb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andrew Pow

Introduction

Andrew Pow is an accomplished inventor based in Burlington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on ILDR2 antagonists. His research and inventions have the potential to impact therapeutic treatments significantly.

Latest Patents

Andrew Pow holds 1 patent related to his work on ILDR2 antagonists and combinations thereof. This patent describes a novel pharmaceutical combination that includes an ILDR2 antagonist along with one or more other therapeutically active compounds. The invention aims to provide new therapeutic options for various medical conditions.

Career Highlights

Throughout his career, Andrew has worked with prominent companies in the pharmaceutical industry, including Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development.

Collaborations

Andrew has collaborated with notable professionals in his field, including Lars Röse and Uwe Gritzan. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Andrew Pow's contributions to the field of pharmaceuticals through his innovative work on ILDR2 antagonists highlight his role as a significant inventor. His patent and collaborations reflect his commitment to advancing medical science and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…